Thyrocare Technologies IPO GMP History
Thyrocare Technologies IPO has been listed on May 9, 2016 at a listing price of ₹665, against the issue price of ₹446 — a gain of ₹219 (+49.1%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Thyrocare Technologies IPO raised ₹479.21 Cr. through its IPO at a price band of ₹420 to ₹446 per share, with a lot size of 33 shares. The IPO was open for subscription from 27 Apr 2016 to 29 Apr 2016.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 12 Nov, 3:11 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Thyrocare Technologies IPO dates
Key dates from opening to listing. Today is 14 November.
- Open 27 Apr 2016
- Close 29 Apr 2016
- Allotment 05 May 2016
- Refund/credit TBA
- Listing 09 May 2016
Thyrocare Technologies IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹446 |
|---|---|
| Listing gain / loss | +₹219 per share |
| Listing date | 09 May, 2016 |
| Actual listing price | ₹665 (+49.1%) |
Is Thyrocare Technologies IPO GMP reliable?
Grey market premium for Thyrocare Technologies IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Thyrocare Technologies IPO full review for a fundamentals-based assessment before making any grey market trades.
Thyrocare Technologies IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Thyrocare Technologies IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Thyrocare Technologies IPO
Thyrocare Technologies Limited is one of the leading pan India diagnostic chains. Its promoters are A. Velumani and A. Sundararaju.
It conducts medical diagnostic tests and test profiles that help with early detection and management of disorders and diseases.
It runs India's first fully automated diagnostic laboratory and has a presence in more than 2000 cities and towns in India and abroad. As of 30 November 2015 it offered 192 tests.
The IPO was Rs 479.21 crore and was entirely an offer for sale at Rs 446, the top of the Rs 420 to Rs 446 band, so the company received no money.
Frequently asked
What is the GMP of Thyrocare Technologies IPO?
The current Grey Market Premium (GMP) of Thyrocare Technologies IPO is not yet started or active in the market.
What is the Kostak Price of Thyrocare Technologies IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Thyrocare Technologies IPO is not available.
What is the Subject to Sauda Price of Thyrocare Technologies IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Thyrocare Technologies IPO?
Thyrocare Technologies IPO listed on May 9, 2016 at ₹665, against the issue price of ₹446 — a gain of +49.1%.
How did the GMP of Thyrocare Technologies IPO trend before listing?
The GMP of Thyrocare Technologies IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Thyrocare Technologies IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
